Compare TLSA & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLSA | HNVR |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.1M | 167.0M |
| IPO Year | 2017 | 2022 |
| Metric | TLSA | HNVR |
|---|---|---|
| Price | $1.46 | $21.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $24.50 |
| AVG Volume (30 Days) | ★ 139.1K | 11.3K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $28.03 |
| Revenue Next Year | N/A | $8.02 |
| P/E Ratio | ★ N/A | $21.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $18.31 |
| 52 Week High | $2.60 | $24.36 |
| Indicator | TLSA | HNVR |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 30.15 |
| Support Level | $1.30 | $20.72 |
| Resistance Level | $1.50 | $22.53 |
| Average True Range (ATR) | 0.10 | 0.52 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 85.71 | 25.53 |
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.